By Pushkala Aripaka and Bhanvi Satija Jan 20 (Reuters) - Britain's GSK has agreed to buy RAPT Therapeutics for $2.2 billion, ...

The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday.

TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) ...

Thailand’s Public Health Ministry is ramping up efforts to combat the rising obesity rates and the broader issue of NCDs ...

The agency issued a request for more information that will shape new regulation on ingredient transparency.

Americans who smoke may soon be hearing a lot more about Zyn. That's the flavored nicotine pouch that's generated billions in ...

Looser regulations around consumer-grade wearable devices could be a "path to ROI" for health systems—or a "double-edged ...

Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...

The U.S. Food and Drug Administration (FDA) has upgraded a voluntary recall of grated Pecorino Romano cheese products to a ...

Flavored nicotine pouches called Zyn could soon be legally advertised as a lower-risk option for adults who smoke, as federal ...

The Food and Drug Administration announced that a recall of cookie products has been upgraded to its most serious risk ...

The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...